"Counterfeit Medicine Network Supplying Hospitals Busted Across Six States"
Spurious drug
a drug that is counterfeit, falsely labelled, or imitative of another drug's identity or source.
CDSCO
Central Drugs Standard Control Organisation, India's apex national drug regulatory body under the Health Ministry.
India is one of the world's largest producers of pharmaceutical products and supplies medicines to over 200 countries. This scale creates a large, complex supply chain that is vulnerable to infiltration by criminal networks. Counterfeit medicines, products that are deliberately mislabelled, repackaged, or chemically adulterated, represent a serious convergence of public health failure and organised crime.
The regulatory framework for medicines in India rests primarily on the Drugs and Cosmetics Act, 1940, which defines standards for manufacture, sale, and distribution of drugs. The Central Drugs Standard Control Organisation (CDSCO) at the national level and State Drug Regulatory Authorities (SDRAs) at the state level share enforcement responsibility. The Drug Controller General of India (DCGI) oversees licensing and quality standards. Despite this framework, enforcement gaps, particularly in the secondary and tertiary distribution chain, allow counterfeit products to reach end consumers. Illicit pharmaceutical networks share structural features with other organised criminal supply chains: fake documentation, multi-state distribution, layered intermediaries, and financial flows that resemble money laundering. The 2018 UPSC Mains question on drug trafficking explicitly linked illicit trade to money laundering and gunrunning, and counterfeit medicine networks exhibit the same financial opacity, fake bills, discounted bulk supply, and cash-based transactions that obscure the money trail.
The internal security dimension arises because such networks operate across state boundaries, involve multiple actors (manufacturers, distributors, medical representatives, storage facilities), and can be linked to broader organised crime. When life-saving drugs and ICU medicines are counterfeited, the threat extends beyond individual patients to the reliability of the entire healthcare system.
Counterfeit medicines typically operate through one of three mechanisms. First, rebranding: low-cost or generic medicines are purchased and resold under premium brand names at higher margins. Second, repackaging of expired medicines: expired stock is transferred into new containers with fresh labels and counterfeit batch numbers, making them appear valid. Third, label counterfeiting: genuine-looking packaging of reputed pharmaceutical companies is replicated and affixed to substandard or entirely different products.
The distribution model mirrors legitimate pharmaceutical supply chains. Medical representatives act as the sales force, approaching hospitals, clinics, and pharmacies. Deep discounts, reportedly around 50% in the Bengaluru case, are used as the entry point, exploiting procurement pressure on hospital administrators to reduce costs. …
India's proximity to two of the world's biggest illicit opium-growing states has enhanced her internal security concerns. Explain the linkages between drug trafficking and other illicit activities such as gunrunning, money laundering and human trafficking. What counter-measures should be taken to prevent the same?
Analyse the multidimensional challenges posed by external state and non-state actors, to the internal security of India. Also discuss measures required to be taken to combat these threats.
Consider the following statements regarding the regulation of drugs in India:
1.The Drugs and Cosmetics Act, 1940 is the primary legislation governing manufacture, sale, and distribution of drugs.
2.Drug regulation is a subject exclusively under the Union List of the Seventh Schedule.
3.The Drug Controller General of India (DCGI) heads the Central Drugs Standard Control Organisation (CDSCO).
4.Manufacturing spurious drugs that cause death is punishable with imprisonment up to ten years under the Drugs and Cosmetics Act.
Which of the statements given above are correct?
With reference to counterfeit and spurious medicines in India, consider the following statements:
1.'Spurious drug' and 'adulterated drug' are defined as the same category under the Drugs and Cosmetics Act, 1940.
2.State Drug Regulatory Authorities are responsible for licensing drug manufacturers and distributors at the state level.
3.Batch-number blocking on State FDA portals is a mechanism used to alert the supply chain about suspect medicines.
Which of the statements given above is/are correct?
Match the following regulatory bodies with their primary mandate in India's pharmaceutical governance:
List I (Body) — List II (Mandate)
A.CDSCO — 1. Licensing of drug manufacturers at the state level
B.State Drug Regulatory Authority — 2. Approval of new drugs and clinical trials at the national level
C.Drug Controller General of India — 3. Heading the apex national drug regulatory body
D.Narcotics Control Bureau — 4. Enforcement of the NDPS Act and control of narcotic substances
Consider the following statements about the constitutional and legal framework for drug regulation in India:
1.Drug regulation is listed under the Concurrent List, enabling both Parliament and state legislatures to enact laws on the subject.
2.The Drugs and Cosmetics Act, 1940 was enacted before India's independence.
3.The Narcotic Drugs and Psychotropic Substances Act, 1985 and the Drugs and Cosmetics Act, 1940 are administered by the same ministry.
Which of the statements given above is/are correct?
Want the full note, Prelims Facts & MCQ answers?
Create a free account — takes less than a minute.
Create free account